AtriCure Total Current Assets 2010-2024 | ATRC

AtriCure total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
AtriCure Annual Total Current Assets
(Millions of US $)
2023 $266
2022 $215
2021 $196
2020 $307
2019 $143
2018 $175
2017 $82
2016 $86
2015 $75
2014 $94
2013 $52
2012 $29
2011 $31
2010 $31
2009 $31
AtriCure Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $269
2024-06-30 $253
2024-03-31 $245
2023-12-31 $266
2023-09-30 $253
2023-06-30 $238
2023-03-31 $238
2022-12-31 $215
2022-09-30 $212
2022-06-30 $206
2022-03-31 $200
2021-12-31 $196
2021-09-30 $196
2021-06-30 $236
2021-03-31 $298
2020-12-31 $307
2020-09-30 $296
2020-06-30 $292
2020-03-31 $127
2019-12-31 $143
2019-09-30 $138
2019-06-30 $147
2019-03-31 $155
2018-12-31 $175
2018-09-30 $88
2018-06-30 $87
2018-03-31 $85
2017-12-31 $82
2017-09-30 $82
2017-06-30 $81
2017-03-31 $79
2016-12-31 $86
2016-09-30 $84
2016-06-30 $86
2016-03-31 $65
2015-12-31 $75
2015-09-30 $84
2015-06-30 $91
2015-03-31 $93
2014-12-31 $94
2014-09-30 $91
2014-06-30 $93
2014-03-31 $107
2013-12-31 $52
2013-09-30 $49
2013-06-30 $53
2013-03-31 $54
2012-12-31 $29
2012-09-30 $30
2012-06-30 $31
2012-03-31 $33
2011-12-31 $31
2011-09-30 $32
2011-06-30 $33
2011-03-31 $34
2010-12-31 $31
2010-09-30 $32
2010-06-30 $31
2010-03-31 $30
2009-12-31 $31
2009-09-30 $31
2009-06-30 $31
2009-03-31 $24
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.916B $0.465B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.047B 28.90
Boston Scientific (BSX) United States $154.056B 41.59
Stryker (SYK) United States $148.022B 31.82
EssilorLuxottica (ESLOY) France $137.298B 0.00
Medtronic (MDT) Ireland $115.624B 16.89
Lonza Group Ag (LZAGY) Switzerland $46.792B 0.00
Haleon (HLN) United Kingdom $45.950B 29.85
GE HealthCare Technologies (GEHC) United States $41.418B 20.17
Agilent Technologies (A) United States $38.594B 25.57
ResMed (RMD) United States $33.728B 25.98
Terumo (TRUMY) Japan $25.984B 36.95
Koninklijke Philips (PHG) Netherlands $24.420B 17.44
Zimmer Biomet Holdings (ZBH) United States $21.098B 13.25
Insulet (PODD) United States $19.908B 85.13
Baxter (BAX) United States $17.948B 12.94
Smith & Nephew SNATS (SNN) United Kingdom $11.490B 0.00
Sunny Optical Technology (SNPTF) China $11.331B 0.00
BellRing Brands (BRBR) United States $9.348B 35.03
Demant (WILYY) Denmark $8.092B 0.00
Bio-Rad Laboratories (BIO) United States $7.847B 27.17
Lantheus Holdings (LNTH) United States $5.489B 12.75
Prestige Consumer Healthcare (PBH) United States $4.215B 20.11
ICU Medical (ICUI) United States $3.924B 37.35
Envista Holdings (NVST) United States $3.683B 29.30
Perrigo (PRGO) Ireland $3.443B 10.14
Haemonetics (HAE) United States $3.312B 15.58
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.850B 19.20
QuidelOrtho (QDEL) United States $2.822B 23.71
LeMaitre Vascular (LMAT) United States $2.294B 55.75
Neogen (NEOG) United States $2.261B 26.05
Green Thumb Industries (GTBIF) United States $1.494B 26.06
InMode (INMD) Israel $1.330B 11.12
BioLife Solutions (BLFS) United States $1.193B 0.00
AdaptHealth (AHCO) United States $1.150B 8.22
Maravai LifeSciences Holdings (MRVI) United States $1.013B 0.00
Curaleaf Holdings (CURLF) Canada $0.920B 0.00
CeriBell (CBLL) United States $0.911B 0.00
Phibro Animal Health (PAHC) United States $0.896B 13.74
Evolus (EOLS) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.657B 0.00
Valneva SE (VALN) France $0.635B 0.00
VAREX IMAGING (VREX) United States $0.538B 23.32
Omeros (OMER) United States $0.503B 0.00
Surmodics (SRDX) United States $0.501B 0.00
Owens & Minor (OMI) United States $0.493B 3.85
SNDL (SNDL) Canada $0.439B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
ZimVie (ZIMV) United States $0.368B 30.98
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.349B 0.00
Quanterix (QTRX) United States $0.311B 0.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Aurora Cannabis (ACB) Canada $0.308B 56.10
Cerus (CERS) United States $0.305B 0.00
Viemed Healthcare (VMD) United States $0.300B 28.52
OraSure Technologies (OSUR) United States $0.298B 19.95
Biote (BTMD) United States $0.252B 5.52
Canopy Growth (CGC) Canada $0.252B 0.00
Zynex (ZYXI) United States $0.234B 49.07
Sanuwave Health (SNWV) United States $0.231B 3.24
High Tide (HITI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.204B 15.21
Brainsway (BWAY) Israel $0.184B 97.80
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
MacroGenics (MGNX) United States $0.166B 0.00
TerrAscend (TSNDF) Canada $0.164B 0.00
Organigram Holdings (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.137B 17.17
Jin Medical (ZJYL) China $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.092B 12.92
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.083B 0.00
InterCure (INCR) Israel $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.069B 0.00
Exagen (XGN) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.057B 29.17
Apyx Medical (APYX) United States $0.054B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.046B 13.24
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.042B 0.00
INLIF (INLF) $0.032B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Allurion Technologies (ALUR) United States $0.009B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00